Tennessee HB0192 establishes the Individualized Investigational Treatment Act, allowing eligible patients to access personalized treatments.

Tennessee HB0192, known as the Individualized Investigational Treatment Act, allows eligible patients with life-threatening or severely debilitating illnesses to access personalized treatments. These treatments, unique to the patient's genetic profile, can be provided by eligible facilities or manufacturers without compensation. The bill ensures that healthcare providers cannot face disciplinary action for recommending such treatments and that patients' heirs are not liable for treatment-related debt if the patient dies.

Tennessee HB0192 establishes the Individualized Investigational Treatment Act, allowing eligible patients to access personalized treatments.

Tennessee HB0192, known as the Individualized Investigational Treatment Act, allows eligible patients with life-threatening or severely debilitating illnesses to access personalized treatments. These treatments, unique to the patient's genetic profile, can be provided by eligible facilities or manufacturers without compensation. The bill ensures that healthcare providers cannot face disciplinary action for recommending such treatments and that patients' heirs are not liable for treatment-related debt if the patient dies.